Published :
Tables : 120
Figures : 40
Category : Healthcare
No. of Pages : 200
Report Code : HC-1263
Dental Biomaterials Market Introduction: Dental Biomaterials Market is estimated to value over USD 10 billion by 2027 end and register a CAGR of over 6.4% during the forecast period 2020 to 2027. The dental biomaterials are synthetic or biological products usually used for restoring periodontal structures and tooth-supporting structures like soft tissues and bones. Bone graft membranes, soft tissue products for regeneration and materials are commonly used for procedures of oral regeneration. A rising number of implant procedures across the world and an increase in the geriatric patient population with some or no teeth have resulted in the increased requirement of bone graft materials. An increase in dental tourism in developing nations and a rise in the number of dental diseases are projected to escalate the market growth in the upcoming years. The global dental biomaterials market is bifurcated based on application, product, end-user and region. Based on the product, the market is categorised into dental membranes, soft tissue regeneration products and bone graft materials. The market segment that predicted to hold a leading market share over the forecast period is bone graft material segment and it is due to an increase in the utilization of xenografts, synthetic grafts and allografts in periodontal defects treatment. On the basis of the application, the market is segmented into periodontology, implantology, and others. In 2017, implantology accounted for a major market share, due to a rising number of implant-related procedures worldwide. Based on the end-user, the market is categorised into dental clinics and hospitals. The hospitals segment is predicted to showcase substantial proliferation in the upcoming years. Key market players included in the global dental biomaterials industry are Straumann Holding AG, Geistlich Pharma AG, Zimmer Biomet Holdings Inc., Danaher Corp., Dentsply Sirona Inc., 3M Company, Royal DSM, Carpenter Technology Corp., Kuraray CO.Ltd., Medtronic Ltd., Henry Schein Inc., Mitsui Chemicals Inc., Victrex PLC, Ivoclar Vivadent AG, GC Corp., Keystone Dental Ltd. Datum Dental Ltd., Bego Medical GmbH, Cam Bioceramics B.V. Dental Biomaterials Market Segmentation: By Type Metallic Biomaterials Titanium Stainless Steel Chromium Alloys Other Metallic Biomaterials Ceramic Biomaterials Polymeric Biomaterials Metal-Ceramic Biomaterials Natural Biomaterials By Application Implantology Prosthodontist Orthodontist Others By End User Dental Product Manufacturers Dental Laboratories Dental Hospitals and Clinics Dental Academics and Research Institutes By Region Europe North America Asia Pacific Latin America Middle East & Africa FutureWise Key Takeaways Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global dental biomaterials market by type, by application, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Dental Biomaterials Market is estimated to value over USD 10 billion by 2027 end and register a CAGR of over 6.4% during the forecast period 2020 to 2027.
The dental biomaterials are synthetic or biological products usually used for restoring periodontal structures and tooth-supporting structures like soft tissues and bones. Bone graft membranes, soft tissue products for regeneration and materials are commonly used for procedures of oral regeneration. A rising number of implant procedures across the world and an increase in the geriatric patient population with some or no teeth have resulted in the increased requirement of bone graft materials. An increase in dental tourism in developing nations and a rise in the number of dental diseases are projected to escalate the market growth in the upcoming years.
The global dental biomaterials market is bifurcated based on application, product, end-user and region. Based on the product, the market is categorised into dental membranes, soft tissue regeneration products and bone graft materials. The market segment that predicted to hold a leading market share over the forecast period is bone graft material segment and it is due to an increase in the utilization of xenografts, synthetic grafts and allografts in periodontal defects treatment. On the basis of the application, the market is segmented into periodontology, implantology, and others. In 2017, implantology accounted for a major market share, due to a rising number of implant-related procedures worldwide. Based on the end-user, the market is categorised into dental clinics and hospitals. The hospitals segment is predicted to showcase substantial proliferation in the upcoming years.
Key market players included in the global dental biomaterials industry are Straumann Holding AG, Geistlich Pharma AG, Zimmer Biomet Holdings Inc., Danaher Corp., Dentsply Sirona Inc., 3M Company, Royal DSM, Carpenter Technology Corp., Kuraray CO.Ltd., Medtronic Ltd., Henry Schein Inc., Mitsui Chemicals Inc., Victrex PLC, Ivoclar Vivadent AG, GC Corp., Keystone Dental Ltd. Datum Dental Ltd., Bego Medical GmbH, Cam Bioceramics B.V.
Dental Biomaterials Market Segmentation:
By Type
By Application
By End User
By Region
FutureWise Key Takeaways
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Dental Biomaterials Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Dental Biomaterials Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Dental Biomaterials Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Dental Biomaterials Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Dental Biomaterials Market, By Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Metallic Biomaterials 7.2. Titanium 7.3. Stainless Steel 7.4. Chromium Alloys 7.5. Other Metallic Biomaterials 7.6. Ceramic Biomaterial 7.7. Polymeric Biomaterials 7.8. Metal-Ceramic Biomaterials 7.9. Natural Biomaterials 8. Global Dental Biomaterials Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Implantology 8.2. Prosthodontist 8.3. Orthodontist 8.4. Others 9. Global Dental Biomaterials Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Dental Product Manufacturers 9.2. Dental Laboratories 9.3. Dental Hospitals and Clinics 9.4. Dental Academics and Research Institutes 10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2020-2027 11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2020-2027 12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2020-2027 13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1.Straumann Holding AG 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Geistlich Pharma AG 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Zimmer Biomet Holdings Inc 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Danaher Corp. 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Dentsply Sirona Inc. 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 3M Company 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Royal DSM 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Carpenter Technology Corp. 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Kuraray CO.Ltd., 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Medtronic Ltd. 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11. Henry Schein Inc. 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12. Mitsui Chemicals Inc. 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13. Victrex PLC 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 15.14. Ivoclar Vivadent AG 15.14.1. Company Overview 15.14.2. Product Portfolio 15.14.3. SWOT Analysis 15.14.4. Financial Overview 15.14.5. Strategic Overview 15.15. GC Corp. 15.15.1. Company Overview 15.15.2. Product Portfolio 15.15.3. SWOT Analysis 15.15.4. Financial Overview 15.15.5. Strategic Overview 15.16. Keystone Dental Ltd. 15.16.1. Company Overview 15.16.2. Product Portfolio 15.16.3. SWOT Analysis 15.16.4. Financial Overview 15.16.5. Strategic Overview 15.17. Datum Dental Ltd. 15.17.1. Company Overview 15.17.2. Product Portfolio 15.17.3. SWOT Analysis 15.17.4. Financial Overview 15.17.5. Strategic Overview 15.18. Bego Medical GmbH 15.18.1. Company Overview 15.18.2. Product Portfolio 15.18.3. SWOT Analysis 15.18.4. Financial Overview 15.18.5. Strategic Overview 15.19. Cam Bioceramics B.V. 15.19.1. Company Overview 15.19.2. Product Portfolio 15.19.3. SWOT Analysis 15.19.4. Financial Overview 15.19.5. Strategic Overview 16. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics